Search

Bingyuan Y Wu

from North Wales, PA
Age ~58

Bingyuan Wu Phones & Addresses

  • 113 Carson Dr, North Wales, PA 19454 (215) 368-4730
  • 757 Main St, Lansdale, PA 19446 (215) 855-4122
  • Hatfield, PA
  • 23 Pebble Dr, Horsham, PA 19044 (215) 675-3196
  • Bensalem, PA
  • Detroit, MI
  • 757 E Main St APT D304, Lansdale, PA 19446

Publications

Us Patents

Expression Of Soluble Therapeutic Proteins

View page
US Patent:
8043833, Oct 25, 2011
Filed:
Sep 6, 2006
Appl. No.:
12/092125
Inventors:
Marc F. Schwartz - West Windsor NJ, US
Bingyuan Wu - Horsham PA, US
Aliakbar Mobasseri - Voorhees NJ, US
Shawn A. DeFrees - North Wales PA, US
Tarik Soliman - Chester Springs PA, US
Karl F. Johnson - Hatboro PA, US
Assignee:
Novo Nordisk A/S - Bagsvaerd
International Classification:
C12P 21/04
C12P 21/06
C12N 15/00
A61K 1/00
C07K 1/00
A23J 1/00
US Classification:
435 712, 435 691, 435440, 530399, 530350, 530412
Abstract:
The present invention provides enhanced methods of producing soluble, active fibroblast growth factor-20 (FGF-20), FGF-21, neurotrophin-3 (NT-3), growth hormone (GH), granulocyte colony stimulating factor (G-CSF), or glucocerebrosidase proteins in microorganisms that have an oxidizing environment.

Glycopegylated Granulocyte Colony Stimulating Factor

View page
US Patent:
20070254836, Nov 1, 2007
Filed:
Dec 3, 2004
Appl. No.:
10/579620
Inventors:
Shawn Defrees - North Wales PA, US
Henrik Clausen - Holte, DK
David Zopf - Wayne PA, US
Zhi-Guang Wang - Dresher PA, US
Caryn Bowe - Doylestown PA, US
Marc Schwartz - West Windsor NJ, US
Bingyuan Wu - Horsham PA, US
International Classification:
A61K 38/22
A61P 31/00
A61P 37/04
C07K 14/75
C12P 21/06
US Classification:
514012000, 435068100, 435070100, 530399000, 530410000
Abstract:
The present invention provides conjugates between Granulocyte Colony Stimulating Factor and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention.

Il-17A Antagonists

View page
US Patent:
20110236390, Sep 29, 2011
Filed:
Oct 29, 2010
Appl. No.:
12/915445
Inventors:
Juan Carlos Almagro - Radnor PA, US
Daniela Della Ducata - Martinsried/Planegg, DE
Merle Elloso - Radnor PA, US
Jinquan Luo - Radnor PA, US
Thomas Malia - Radnor PA, US
Michael Naso - Radnor PA, US
Galina Obmolova - Radnor PA, US
Robert Rauchenberger - Martinsried/Planegg, DE
Mark Rutz - Lena-Christ-Strasse, DE
Raymond Sweet - Radnor PA, US
Susann Taudte - Radnor PA, US
Bingyuan Wu - Radnor PA, US
Sheng-Jiun Wu - Radnor PA, US
International Classification:
A61K 39/395
C12N 15/63
C12N 5/10
C07K 16/24
C12N 1/00
C07H 21/00
C07K 1/107
A61P 29/00
A61P 11/00
A61P 17/06
A61P 11/06
A61P 19/02
US Classification:
4241391, 4353201, 435331, 435419, 5303879, 435243, 5303911, 536 2353, 530351
Abstract:
Interleukin-17A (IL-17A) antibody antagonists, polynucleotides encoding IL-17A antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
Bingyuan Y Wu from North Wales, PA, age ~58 Get Report